Clinical Trials Logo

Filter by:
NCT ID: NCT03441568 Completed - Atopic Dermatitis Clinical Trials

In-home Use Test of the New Modified Diprobase Formulation to Assess the Safety and Tolerability in Infants and Children Under Physician's Control

Start date: September 26, 2018
Phase: N/A
Study type: Interventional

To investigate the safety and tolerability of the modified Diprobase formulation over 14 days in infants and children with a history of Atopic Dermatitis (AD).

NCT ID: NCT03441555 Completed - Clinical trials for Acute Myeloid Leukemia (AML)

A Study of Venetoclax and Alvocidib in Patients With Relapsed/Refractory Acute Myeloid Leukemia

Start date: May 30, 2018
Phase: Phase 1
Study type: Interventional

An open-label, dose-escalation study to assess the safety and pharmacokinetics (PK), to determine the dose limiting toxicity (DLT) and the recommended Phase 2 dose (RPTD), and to assess the preliminary efficacy of alvocidib with venetoclax when co-administered in participants with relapsed or refractory (R/R) acute myeloid leukemia (AML).

NCT ID: NCT03441178 Completed - Clinical trials for Colectomy; Gynecological; Thoracic

A Prospective, Multi-Center Evaluation of the ENSEAL X1 Large Jaw Tissue Sealer

Start date: March 13, 2018
Phase: N/A
Study type: Interventional

This prospective, single-arm, multi-center, evaluation will collect clinical data in a post-market setting. The three types of procedures studied will be colectomy, gynecological, and thoracic. Investigators will perform each procedure using the device in compliance with their standard surgical approach and the ENSEAL X1 instructions for use.

NCT ID: NCT03440814 Completed - Clinical trials for Prader-Willi Syndrome

A Study of Diazoxide Choline in Patients With Prader-Willi Syndrome

Start date: May 9, 2018
Phase: Phase 3
Study type: Interventional

The purpose of this is study is to evaluate the effects of DCCR (diazoxide choline controlled release tablets) in children and adults with Prader-Willi syndrome.

NCT ID: NCT03439917 Completed - Insulin Resistance Clinical Trials

Effects of Carnitine Supplementation on Liver and Muscle

ECLIPSE
Start date: April 2, 2018
Phase: N/A
Study type: Interventional

It will be evaluated whether carnitine, a dietary supplement, reduces liver fat and improves metabolism in individuals who have a high concentration of fat within their liver. Participants will be given either Carnitine or placebo, together with a meal replacement milkshake twice daily for 6 months.

NCT ID: NCT03439878 Completed - Clinical trials for Cardiovascular Risk Factor

Effect of Galactose Ingestion on Postprandial Lipemia

Start date: February 1, 2018
Phase: N/A
Study type: Interventional

This study aims to assess the postprandial triglyceride response to the ingestion of a high-fat meal with co-ingestion of either galactose, or glucose.

NCT ID: NCT03439813 Completed - Stroke Clinical Trials

Treating Anxiety After Stroke (TASK)

TASK
Start date: January 17, 2018
Phase: N/A
Study type: Interventional

The TASK (Treating Anxiety after StroKe) trial is a feasibility randomized controlled trial. It aims to evaluate the feasibility of i) web-enabled trial procedures, and ii) the TASK intervention in stroke and TIA patients

NCT ID: NCT03439670 Completed - Clinical trials for Duchenne Muscular Dystrophy

A Study to Assess the Efficacy and Safety of Vamorolone in Boys With Duchenne Muscular Dystrophy (DMD)

Start date: June 29, 2018
Phase: Phase 2
Study type: Interventional

Brief Summary: This Phase IIb study is a randomized, double-blind, parallel group, placebo and active-controlled study to evaluate the efficacy, safety, PD, and population PK of vamorolone administered orally at daily doses of 2.0 mg/kg and 6.0 mg/kg versus prednisone 0.75 mg/kg/day and placebo over a Treatment Period of 24 weeks, and to evaluate persistence of effect over a Treatment Period of 48 weeks in ambulant boys ages 4 to <7 years with DMD.

NCT ID: NCT03439605 Completed - Hemolysis Clinical Trials

Effect of in Vitro Haemolysis on Serum High Sensitivity Troponin T Measurements From Patients in Accident & Emergency

Start date: September 9, 2017
Phase: N/A
Study type: Observational

This study will be investigating how a common blood test for identifying heart damage (Troponin T) is affected by red blood cell damage in the blood sample (Haemolysis). It is already known that damage to the red blood cells during or after blood sample collection can cause falsely low test results however the exact amount is not clear. Some previous studies suggest that a much higher amount of red blood cell damage could be allowable when reporting the test results. This study will mimic the type of red blood cell damage that occurs in the hospital and determine what degree of damage or 'haemolysis' causes a significant reduction in the test result and therefore determine an allowable limit for safely reporting the test result. The results of this study may help provide an evidence based approach to improving current practice and may lead to fewer rejected blood samples, fewer repeat tests, improved A&E treatment times, general cost savings and an improved service to patients.

NCT ID: NCT03439345 Completed - Clinical trials for Diabetic Retinopathy

Lowering Events in Non-proliferative Retinopathy in Scotland

LENS
Start date: July 23, 2018
Phase: Phase 4
Study type: Interventional

LENS is a streamlined multicentre randomized placebo-controlled parallel-group trial investigating the effect of fenofibrate treatment on the progression of diabetic retinopathy/maculopathy